0–4 | years | 5–9 | years | 10–14 | years | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 2020 | 2021 | 2019–2021 | 2019 | 2020 | 2021 | 2019–2021 | 2019 | 2020 | 2021 | 2019–2021 | |
N° patients | 5 | 15 | 16 | 36 | 19 | 23 | 18 | 60 | 19 | 15 | 24 | 58 |
DKA | ||||||||||||
Yes | 2 (40%) | 9 (60%) | 6 (37.5%) | 17 (47.2%) | 9 (47.4%) | 10 (43.5%) | 9 (50%) | 28 (46.7%) | 8 (42.1%) | 8 (53.3%) | 10 (41.7%) | 26 (44.8%) |
No | 3 (60%) | 6 (40%) | 10 (62.5%) | 19 (52.8%) | 10 (52.6%) | 13 (56.5%) | 9 (50%) | 32 (53.3%) | 11 (57.9%) | 7 (46.7%) | 14 (58.3%) | 32 (55.2%) |
Severity DKA | ||||||||||||
Mild | 0 (0%) | 2 (22.2%) | 2 (33.3%) | 4 (23.5%) | 3 (33.3%) | 4 (40%) | 2 (22.2%) | 9 (32.1%) | 4 (50%) | 5 (62.5%) | 5 (50%) | 14 (53.8%) |
Moderate | 0 (0%) | 1 (11.1%) | 1 (16.7%) | 2 (11.8%) | 2 (22.2%) | 3 (30%) | 5 (55.6%) | 10 (35.7%) | 3 (37.5%) | 0 (0%) | 3 (30%) | 6 (23.1%) |
Severe | 2 (100%) | 6 (66.7%) | 3 (50%) | 11 (64.7%) | 4 (44.4%) | 3 (30%) | 2 (22.2%) | 9 (32.1%) | 1 (12.5%) | 3 (37.5%) | 2 (20%) | 6 (23.1%) |